Evidence map›Paper›PMID 33628377›Full record

ArticleOxidative medicine and cellular longevity2021

Different Doses of

Cemal Orhan, Mehmet Tuzcu, Hasan Gencoglu, Emre Sahin, Nurhan Sahin, Ibrahim Hanifi Ozercan, Tejas Namjoshi, Vandita Srivastava, Abhijeet Morde, Deshanie Rai and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Effects of Integrated Extracts ofAntioxidants (Basel, Switzerland) · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Cemal OrhanDepartment of Animal Nutrition, Faculty of Veterinary Science, Firat University, Elazig 23119, Turkey.
Mehmet TuzcuDivision of Biology, Faculty of Science, Firat University, Elazig 23119, Turkey.
Hasan GencogluDivision of Biology, Faculty of Science, Firat University, Elazig 23119, Turkey.
Emre SahinDepartment of Animal Nutrition, Faculty of Veterinary Science, Firat University, Elazig 23119, Turkey.
Nurhan SahinDepartment of Animal Nutrition, Faculty of Veterinary Science, Firat University, Elazig 23119, Turkey.
Ibrahim Hanifi OzercanDepartment of Pathology, Faculty of Medicine, Firat University, Elazig 23119, Turkey.
Tejas NamjoshiOmniActive Health Technologies, Biotechnology Park, Pune 411057, India.
Vandita SrivastavaOmniActive Health Technologies, Biotechnology Park, Pune 411057, India.
Abhijeet MordeOmniActive Health Technologies, Wagle Estate, Thane 400604, India.
Deshanie RaiOmniActive Health Technologies Inc, Morristown, NJ 07960, USA.
Muralidhara PadigaruOmniActive Health Technologies, Wagle Estate, Thane 400604, India.
Kazim SahinDepartment of Animal Nutrition, Faculty of Veterinary Science, Firat University, Elazig 23119, Turkey.ORCID https://orcid.org/0000-0001-9542-5244
Fırat University · TROmniActive Health Technologies (India) · INOmniActive Health Technologies (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinal damage associated with loss of photoreceptors is a hallmark of eye diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Potent nutritional antioxidants were previously shown to abate the degenerative process in AMD.

Indexed as

LightAnimalsBeta-CryptoxanthinDose-Response Relationship, DrugEye ProteinsInterleukin-1betaInterleukin-6MaleMalondialdehydeModels, BiologicalNF-kappa BOxidative StressRatsRats, WistarRetinaVascular Endothelial Growth Factor ABeta-CryptoxanthinEye ProteinsInterleukin-1betaInterleukin-6MalondialdehydeNF-kappa BVascular Endothelial Growth Factor A

Identifiers

PMID33628377
PMCPMC7895591
OpenAlexW3126151811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.